# The Human Medicines Regulations 2012, Paragraph 21


For medicinal products included on the list referred to in Article 23 of Regulation (EC) No 726/2004 or regulation 202A, as the case may be, the symbol and statement “▼ This medicinal product is subject to additional monitoring”.

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/schedule/12/paragraph/21 (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/schedule-12/paragraph-21
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.